BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26894965)

  • 1. Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia.
    Suleiman Y; Dalia S; Liu JJ; Bowers JW; Padron E; Lancet JE; Fulp W; Moscinski LC; Komrokji RS; Zuckerman KS; Zhang L
    Leuk Res; 2016 Mar; 42():52-8. PubMed ID: 26894965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database.
    Shukron O; Vainstein V; Kündgen A; Germing U; Agur Z
    Am J Hematol; 2012 Sep; 87(9):853-60. PubMed ID: 22674538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemic transformation in essential thrombocythemia.
    Bhatt VR
    Future Oncol; 2014 Dec; 10(16):2593-602. PubMed ID: 25531047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?
    Björkholm M; Hultcrantz M; Derolf ÅR
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):141-53. PubMed ID: 25189725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
    Neukirchen J; Lauseker M; Hildebrandt B; Nolting AC; Kaivers J; Kobbe G; Gattermann N; Haas R; Germing U
    Cancer; 2017 Dec; 123(23):4608-4616. PubMed ID: 28746789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential thrombocythemia with ringed sideroblasts: a heterogeneous spectrum of diseases, but not a distinct entity.
    Schmitt-Graeff A; Thiele J; Zuk I; Kvasnicka HM
    Haematologica; 2002 Apr; 87(4):392-9. PubMed ID: 11940483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.
    Sever M; Kantarjian H; Pierce S; Jain N; Estrov Z; Cortes J; Verstovsek S
    Int J Hematol; 2009 Nov; 90(4):522-525. PubMed ID: 19728024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple factors in the transformation of essential thrombocythemia to acute leukemia or myelodysplastic syndrome.
    Liu TC; Suri R
    Blood; 1998 Aug; 92(4):1465-6. PubMed ID: 9694744
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.
    Germing U; Lauseker M; Hildebrandt B; Symeonidis A; Cermak J; Fenaux P; Kelaidi C; Pfeilstöcker M; Nösslinger T; Sekeres M; Maciejewski J; Haase D; Schanz J; Seymour J; Kenealy M; Weide R; Lübbert M; Platzbecker U; Valent P; Götze K; Stauder R; Blum S; Kreuzer KA; Schlenk R; Ganser A; Hofmann WK; Aul C; Krieger O; Kündgen A; Haas R; Hasford J; Giagounidis A
    Leukemia; 2012 Jun; 26(6):1286-92. PubMed ID: 22289990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
    Leleu X; Soumerai J; Roccaro A; Hatjiharissi E; Hunter ZR; Manning R; Ciccarelli BT; Sacco A; Ioakimidis L; Adamia S; Moreau AS; Patterson CJ; Ghobrial IM; Treon SP
    J Clin Oncol; 2009 Jan; 27(2):250-5. PubMed ID: 19064987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study.
    Shrestha R; Giri S; Armitage JO; Bhatt VR
    Future Oncol; 2017 Jun; 13(14):1239-1246. PubMed ID: 28589759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
    Neumann F; Gattermann N; Barthelmes HU; Haas R; Germing U
    Leuk Res; 2009 Feb; 33(2):232-6. PubMed ID: 18639338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Essential thrombocythemia transformed to acute myeloblastic leukemia].
    Okuda M; Shishido T; Sato A; Nagai T; Sugawara T; Kameoka J; Kaneda K; Meguro K; Fukuhara O; Sakurai T
    Rinsho Ketsueki; 1990 Oct; 31(10):1689-93. PubMed ID: 2255058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study.
    Ye X; Chen D; Zheng Y; Wu C; Zhu X; Huang J
    Hematol Oncol; 2019 Oct; 37(4):438-446. PubMed ID: 31378958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
    Björkholm M; Derolf AR; Hultcrantz M; Kristinsson SY; Ekstrand C; Goldin LR; Andreasson B; Birgegård G; Linder O; Malm C; Markevärn B; Nilsson L; Samuelsson J; Granath F; Landgren O
    J Clin Oncol; 2011 Jun; 29(17):2410-5. PubMed ID: 21537037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Essential thrombocythemia in transformation from myelodysplastic syndrome to acute myeloid leukemia with inv(3) after treatment for gastric cancer].
    Horikoshi M; Machida U; Itikawa M; Seo S; Masuda S; Kurokawa M; Ogawa S; Sunaga S; Honda H; Aoki K; Chiba S; Mitani K; Hirai H; Yazaki Y
    Rinsho Ketsueki; 2000 Jan; 41(1):68-71. PubMed ID: 10695403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.